These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15609993)

  • 1. Solution structure, backbone dynamics, and association behavior of the C-terminal BRCT domain from the breast cancer-associated protein BRCA1.
    Gaiser OJ; Ball LJ; Schmieder P; Leitner D; Strauss H; Wahl M; Kühne R; Oschkinat H; Heinemann U
    Biochemistry; 2004 Dec; 43(51):15983-95. PubMed ID: 15609993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.
    Williams RS; Green R; Glover JN
    Nat Struct Biol; 2001 Oct; 8(10):838-42. PubMed ID: 11573086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
    Williams RS; Lee MS; Hau DD; Glover JN
    Nat Struct Mol Biol; 2004 Jun; 11(6):519-25. PubMed ID: 15133503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of an XRCC1 BRCT domain: a new protein-protein interaction module.
    Zhang X; Moréra S; Bates PA; Whitehead PC; Coffer AI; Hainbucher K; Nash RA; Sternberg MJ; Lindahl T; Freemont PS
    EMBO J; 1998 Nov; 17(21):6404-11. PubMed ID: 9799248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BRCT domain is a phospho-protein binding domain.
    Yu X; Chini CC; He M; Mer G; Chen J
    Science; 2003 Oct; 302(5645):639-42. PubMed ID: 14576433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
    Clapperton JA; Manke IA; Lowery DM; Ho T; Haire LF; Yaffe MB; Smerdon SJ
    Nat Struct Mol Biol; 2004 Jun; 11(6):512-8. PubMed ID: 15133502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets.
    Drikos I; Nounesis G; Vorgias CE
    Proteins; 2009 Nov; 77(2):464-76. PubMed ID: 19452558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-related mutations in BRCA1-BRCT cause long-range structural changes in protein-protein binding sites: a molecular dynamics study.
    Gough CA; Gojobori T; Imanishi T
    Proteins; 2007 Jan; 66(1):69-86. PubMed ID: 17063491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput fluorescence polarization assay to identify small molecule inhibitors of BRCT domains of breast cancer gene 1.
    Lokesh GL; Rachamallu A; Kumar GD; Natarajan A
    Anal Biochem; 2006 May; 352(1):135-41. PubMed ID: 16500609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal denaturation of the BRCT tandem repeat region of human tumour suppressor gene product BRCA1.
    Pyrpassopoulos S; Ladopoulou A; Vlassi M; Papanikolau Y; Vorgias CE; Yannoukakos D; Nounesis G
    Biophys Chem; 2005 Apr; 114(1):1-12. PubMed ID: 15792855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains.
    Magnard C; Bachelier R; Vincent A; Jaquinod M; Kieffer S; Lenoir GM; Venezia ND
    Oncogene; 2002 Oct; 21(44):6729-39. PubMed ID: 12360400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer predisposing mutations in BRCT domains.
    di Masi A; Gullotta F; Cappadonna V; Leboffe L; Ascenzi P
    IUBMB Life; 2011 Jul; 63(7):503-12. PubMed ID: 21698754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions?
    Mark WY; Liao JC; Lu Y; Ayed A; Laister R; Szymczyna B; Chakrabartty A; Arrowsmith CH
    J Mol Biol; 2005 Jan; 345(2):275-87. PubMed ID: 15571721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACCA phosphopeptide recognition by the BRCT repeats of BRCA1.
    Ray H; Moreau K; Dizin E; Callebaut I; Venezia ND
    J Mol Biol; 2006 Jun; 359(4):973-82. PubMed ID: 16698035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins.
    Bork P; Hofmann K; Bucher P; Neuwald AF; Altschul SF; Koonin EV
    FASEB J; 1997 Jan; 11(1):68-76. PubMed ID: 9034168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo.
    Quaresima B; Faniello MC; Baudi F; Crugliano T; Di Sanzo M; Cuda G; Costanzo F; Venuta S
    Oncol Rep; 2006 Oct; 16(4):811-5. PubMed ID: 16969499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.
    Ekblad CM; Friedler A; Veprintsev D; Weinberg RL; Itzhaki LS
    Protein Sci; 2004 Mar; 13(3):617-25. PubMed ID: 14978302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of deletion and site-directed mutations on ligation steps of NAD+-dependent DNA ligase: a biochemical analysis of BRCA1 C-terminal domain.
    Feng H; Parker JM; Lu J; Cao W
    Biochemistry; 2004 Oct; 43(39):12648-59. PubMed ID: 15449954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mapping of BRCT1 domain of BRCA1 with chromatin unfolding activity].
    Ye QN; Hu YF; Zhong HJ; Li R; Huang CF
    Sheng Wu Gong Cheng Xue Bao; 2002 Nov; 18(6):656-61. PubMed ID: 12674632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel domain of BRCA1 interacts with p53 in breast cancer cells.
    Buck M
    Cancer Lett; 2008 Sep; 268(1):137-45. PubMed ID: 18501503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.